A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB
Clinical trial NCT07095855 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07095855
- Sponsor
- Shanghai Zhimeng Biopharma, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2028-01-01
- Enrollment
- 1300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.